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biomarkers are described. Finally, issues re-
garding clinical trials are discussed.
Each chapter starts as a basic overview
and then goes into great detail of each tech-
nique or biomarker. Therefore, this book is
appropriate for scientists of many levels
from graduate and medical students inter-
ested in cancer research to post doctoral fel-
lows and faculty members looking to update
their knowledge of the field. The hierarchi-
cal organization of the book causes some
parts to be repetitive. However, it allows one
to determine which chapters are interesting
before devoting time to reading them. All
sections of the book are well written and up-
to-date. I recommend Cancer Biomarkers:
Analytical Techniques for Discovery to any-
one interested in learning about cancer re-
search from the basic discovery to clinical
stages.
Kathleen Wilson
Yale University
Department of Genetics
The War of the Soups and the
Sparks: The Discovery of Neuro-
transmitters and the Dispute Over
How Nerves Communicate. By Eliot S.
Valenstein. New York: Columbia Univer-
sity Press; 2006, 256 pp. $23.50 Paper-
back. ISBN: 9780231135894.
Neuroscience has a rich history of vig-
orous debate and contentious argument, as
Eliot S. Valenstein effectively illustrates in
The War of the Soups and the Sparks: The
Discovery of Neurotransmitters and the Dis-
pute Over How Nerves Communicate.
Valenstein argues that fundamental discov-
eries that come to shape the course of scien-
tific thought are rarely arrived at in a
straightforward manner and are much more
nuanced than portrayed in the “classic” pri-
mary literature. Rather, discovery results
from the combination of sound scientific ar-
guments, individual personality, and the un-
predictable course of history.
The “war” of neurotransmission that
Valenstein examines in his book encom-
passes one of the key periods in the history
of neuroscience. By the middle of the 20th
century, it was well accepted that neurons
are physically separated from one another
by a narrow space. Discovering how neu-
rons communicate across this cleft was the
next major challenge facing neuroscience
and would set the stage for the next great
conceptual leap in the understanding of the
nervous system. This debate would prima-
rily involve the rapidly advancing fields of
neuropharmacology and electrophysiology,
and this divide, both technically and theoret-
ically, would give rise to the “soup” vs.
“sparks” camps, respectively.
Despite the bellicose title, the majority
of Valenstein’s exposition leisurely travels
the winding road of pharmacological dis-
covery, detailing the personal history of the
major (and minor) players in the chemical
vs. electrical transmission debate along the
way. There is little in the way of technical
examination of the primary literature and as-
sessment of experimental evidence pro-
duced during this great period; in fact, the
“soup vs. sparks” aspect of the book is con-
tained in a single, 14-page chapter. Nonethe-
less, Valenstein does a masterful job of
tracing the history of pharmacological inves-
tigation into excitable tissue, particularly
showing how investigation of neurotrans-
mission arose from the rich tradition of in-
vestigation concerning muscle physiology.
His tone is simultaneously relaxed and eru-
dite, and he constructs a surprisingly com-
pelling “story” from disparate sources.
Valenstein carefully juxtaposes the intellec-
tual climate of scientific discovery with the
dire political climate of early 20th century
Europe, and his narrative takes a serious
tone when he describes the rise of the Nazi
party and its effect upon German science,
and, in particular, the lives of the many Jew-
ish scientists involved in the “soups vs.
sparks” debate. The “war” of the title also
may then metaphorically refer to the events
of World War II, which greatly affected sci-
ence and which Valenstein details wonder-
fully. His thoughtful treatment lends an
appropriate gravitas to the science that
emerged from this period of history. As
mentioned, this is not a book for those de-
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ments and evidence concerning chemical vs.
electrical neurotransmission, although there
is enough detail to pique the interest of the
specialist. Rather, this a book for graduate
or medical students interested in the charac-
ters and events surrounding the discovery of
neurotransmission and also for those stu-
dents of the history of science interested in
how world events shape scientific discovery.
Bilal Haider
Yale University School of Medicine
Department of Neurobiology
Understanding Cancer: A Patient’s
Guide to Diagnosis, Prognosis, and
Treatment. 2nd edition. By C. Norman
Coleman. Baltimore:The John Hopkins
University Press; 2006, 232 pp. $18.95
Paperback. ISBN: 9780801884184.
Awidelyacclaimedguideforcancerpa-
tientsandtheirfamilies,UnderstandingCan-
cer is also an immensely helpful read for
basic cancer scientists who wish to broaden
their perspectives on cancer and appreciate
the potential impact of their research.
This book is part of the National Cancer
Institute’s TASC (Take a Scientist to the
Clinic) seminar series. Coleman begins by
outlining the general processes of diagnosis
and treatment as a “road map” for cancer pa-
tients. Following the “bird’s-eye view,” he
expounds on individual subjects, including
the origin of cancer, information gathering
using diagnostic tests and staging studies,
methods of evaluating treatment efficacy,
and approaches in weighing long-term risks
and benefits of treatment. Conventional
treatment modalities including surgery,
chemotherapy, radiation therapy, bone mar-
row transplantation, and hormonal therapies
are reviewed with the pros and cons of each
option. Combinational regimens composed
of multiple modalities also are covered.The
book includes two significant updates from
the previous edition: discussions on molec-
ular targeted therapy and how clinical trials
are conducted to advance translational med-
icine and grant-limitedpools of volunteering
patients’access to novel therapies. In the last
chapter, four hypothetical patient stories are
presented to illustrate various scenarios from
which readers could learn for their own de-
cision-making process.The appendices con-
sist of a concise review of cancer molecular
biology, as well as useful tools such as
analysis of treatment cost-effectiveness, the
performance status scoring systems, and pa-
tient’s checklist.
Understanding Cancer provides a
handy and informative clinical perspective
in explaining how various procedures in-
cluding diagnosis, staging (clinical and
pathological), treatment, and progress as-
sessment are conducted in the healthcare
system. Charts illustrating medical concepts
and tables listing cancer classifications, ter-
minologies, and current available therapeu-
tics are resourceful references for scientists
thinking about translational medicine. It also
illuminates the quest of the medical commu-
nity for further breakthroughs in molecular
medicine, driven by collaborations among
scientists, clinicians, and patients, to en-
hance the life expectancy and quality of life
for those afflicted by cancer.
Coleman points out that cancer is not
merely a medical issue. Diagnosis of cancer
can complicate various aspects of patients’
lives. Fear of “their own mortality” may
suddenly become more prominent, followed
by concerns for their families’ future wel-
fare, their careers, and the financial stresses
that might accompany the ordeal.Therefore,
personal matters are essential when consid-
ering treatment options. Macroscopically,
cancer causes socio-economical problems.
Government and insurance companies may
make use of the analytical tools introduced
in this book to evaluate appropriate treat-
ments as well as expenditure and reimburse-
ment schemes.
While scientists in cancer research may
skip chapters introducing basic cancer biol-
ogy, Understanding Cancer helps them view
this disease from the perspectives of the pa-
tients and clinicians, as well as policy mak-
ers and healthcare financiers.This book also
serves as an encouraging reminder for basic
scientists that their research can have far-
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